Peter Attia

Addison Public Library — United States

Medicine · Health Sciences

12h-index3.0kcitations19works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(8), Immunotherapy and Immune Responses(7), T-cell and B-cell Immunology(4), Fatty Acid Research and Health(3), Toxin Mechanisms and Immunotoxins(3)

Publications19 total

Associations of serum omega-6 polyunsaturated fatty acids with apolipoprotein B and atherogenic lipoprotein lipids
Journal of clinical lipidology·2025
Associations of serum omega-3 polyunsaturated fatty acids with apolipoprotein B and atherogenic lipoprotein lipids
Journal of clinical lipidology·2025
Broken sleep predicts hardened blood vessels
PLoS Biology·2020· 47 citedOpen Access
Broken sleep predicts hardened blood vessels
Sleep Medicine·2019· 1 cited
Individualized clinical management of patients at risk for Alzheimer's dementia
Alzheimer s & Dementia·2019· 73 citedOpen Access
O4‐06‐04: PRECISION MEDICINE INTERVENTION IN PATIENTS AT RISK FOR ALZHEIMER'S DEMENTIA
Alzheimer s & Dementia·2019Open Access
Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention
Frontiers in Aging Neuroscience·2018· 46 citedOpen Access
Partial Reduction of Human FOXP3+ CD4 T Cells In Vivo After CD25-directed Recombinant Immunotoxin Administration
Journal of Immunotherapy·2008· 65 cited
Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma
Journal of Immunotherapy·2006· 263 citedOpen Access
Selective Elimination of Human Regulatory T Lymphocytes In Vitro With the Recombinant Immunotoxin LMB-2
Journal of Immunotherapy·2006· 73 citedOpen Access
Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade
The Journal of Immunology·2005· 330 cited
Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study
Annals of Surgical Oncology·2005· 489 citedOpen Access
Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma
Journal of Immunotherapy·2005· 289 cited
Cellular mechanisms of anti-tumor responses in patients treated with CTLA-4 blockade
Journal of the American College of Surgeons·2005
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
Journal of Clinical Oncology·2005· 1.0k citedOpen Access
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-CTLA-4
2005· 9 cited
Parathyroid Hormone-Related Protein and Hypercalcemia in Patients With Metastatic Melanoma
American Journal of Clinical Oncology·2003· 19 cited
Factors Associated With Response to High-Dose Interleukin-2 in Patients With Metastatic Melanoma
Journal of Clinical Oncology·2001· 298 cited
Factors A ssociated W ith R esponse t o H igh-Dose Interleukin-2 i n P atients W ith M etastatic M elanoma
2001

Frequent Co-authors

Steven A. Rosenberg(12), Ajay V. Maker(7), Giao Q. Phan(5), Leah Haworth(4), James Chih‐Hsin Yang(3), Richard M. Sherry(3), Suzanne L. Topalian(3), Udai S. Kammula(3), Richard E. Royal(3), Catherine Lévy(3), Sharon Mavroukakis(3), Michael Yellin(3), Richard Isaacson(3), Aneela Rahman(3), Olivia Scheyer(3), Matthew W. Schelke(3), Lisa Mosconi(3), Robert Krikorian(3), Seth M. Steinberg(2), Donald E. White(2)